Smooth muscle myosin heavy chains (MHC) exist in multiple isoforms.
Rabbit smooth muscle contain at least three types of MHC isoforms ; SM1 (204 kDa), SM2 (200 kDa) and SMemb (200 kDa). SM1 and SM2 are specific to smooth muscle, but SMemb is a nonmuscle-type MHC abundantly expressed in the embryonic aorta and in activated mesenchymal cells. We previously reported that these three MHC isoforms are differentially expressed in rabbit during normal vascular development and in experimental arteriosclerosis and demonstrated that MHC isoforms are excellent markers for smooth muscle phenotype.
In order to clarify the clinical significance of MHC isoforms, this article will focus on the expression of smooth muscle MHC isoforms in normally developing and atherosclerotic human arteries, especially in coronary arteries.
We recently isolated and characterized three cDNA clones encoding human SM1, SM2, and SMemb. The expression of SM2 mRNA in the human fetal aorta was significantly lower as compared to SM1 mRNA but the ratio of SM2-to SM1-mRNA was increased after birth. SMemb mRNA in the aorta was decreased after birth . lmmunohistologically, SM1 was constitutively positive from the fetal stage to adulthood in the apparently normal media of the aorta and coronary arteries, whereas SM2 was not detected in fetal arteries of early gestational stage. SM2 was recognized in well-differentiated smooth muscle after perinatal stage.
In the human aorta or coronary arteries , unlike in rabbit, SMemb was detected even in the adult. Mild diffuse intimal thickening in the major coronary arteries of the young was found to be composed of smooth muscle cells , reacting equally to three antibodies for MHC isoforms.
In thickened but non-atheromatous intima , the expression of well-differentiated smooth muscle-specific MHC (SM2) was reduced , especially in the deeper layer. (1) (2) (3) (4) . Two smooth muscle specific MHC isoforms, SM1 and SM2, were generated from a single gene by alternative RNA splicing (2, 5) . Using cDNA probes and isoform-specific antibodies, we have shown that the expression of SM1 and SM2 in rabbit aorta is developmentally regulated ; SM1 is constitutively expres-sed from fetal stage to adulthood, whereas SM2 appears in well-differentiated smooth muscle only after birth (3). We have further revealed the presence of a third type of MHC isoform in rabbit embryonic aorta (4). We referred to this novel MHC isoform as SMemb because it is present in greater abundance in embryonic aortas. This MHC appears to be identical with MHC-B recently characterized in nonmuscle cells (6, 7). The expression pattern of these three MHC proteins in normally developing rabbit aorta is shown in Fig. 1 .
Proliferation and phenotypic modulation of vascular smooth muscle cells are outstanding phenomena occurring during development of atherosclerosis (8-10). Our previous studies on smooth muscle MHC expression in experimental atherosclerosis have clearly shown the importance of smooth muscle MHC isoforms as molecular markers to identify abnormally proliferating smooth muscle cells during formation of vascular lesions (4). Furthermore, we demonstrated a marked contrast in MHC expression between the neointimal and medial smooth muscle cells. The neointimal cells are quite similar to the embryonic smooth muscle cells in that both are positive for SM1 and SMemb, but negative against SM2, thus indicating that when smooth muscle cells proliferate following vascular injury, they regain the embryonic phenotype (4).
In the recent study, we investigated the smooth muscle MHC expression in human arteries at various ages and examined the pathological aspects of smooth muscle cells in atherosclerosis on the basis of MHC expression (11). We have isolated and characterized three types of cDNA clones encoding human vascular smooth muscle MHC isoforms. We have also produced isoform-specific antibodies using the deduced amino acid sequences of the carboxyl terminal end, and determined MHC protein expression at the histological level. We report here differential expression of smooth muscle MHC isoforms during human vascular development and demonstrate that phenotypically modulated smooth muscle cells in atherosclerotic lesions can be identified by altered MHC isoform expression.
Human vascular smooth muscle contains at least three types of MHC isoforms cDNA clones for human SM1, SM2 and SMemb were isolated by screening two cDNA libraries constructed from the human umbilical cord and fetal aorta mRNA (11). SMHC 94 and SMHC 93 encode human SM1 and SM2, respectively, and were highly homologous to SMHC 40 and SMHC 29 encoding the rabbit SM1 and SM2 isoforms (2) . HSME 6 isolated from the fetal aorta cDNA library was highly homologous to the rabbit SMemb (4). At this point, we concluded that human smooth muscle also contain at least three types of MHC isoforms. The nucleotide sequence analysis of the cDNA clones suggested that SM1 and SM2 are generated from a single gene by alternative RNA splicing in an identical manner as already known in rat or rabbit (2, 5, 11), whereas SMemb is encoded by a different MHC gene.
Deduced amino acid comparison of human SM1, SM2, and SMemb is shown in Fig. 2 .
Differential expression of human MHC isoforms during normal vascular development
Rabbit SM1 and SM2 have been found to be specific to vascular and nonvascular smooth muscle (2) . Thus, we concluded that SM1 and SM2 are important molecules to identify smooth muscle cells. SM2 which is found only after birth is especially useful as a marker for well-differentiated smooth muscle cells. On the other hand, SMemb is most abundantly expressed in embryonic smooth muscle, in proliferating smooth muscle cells of experimental atherosclerotic lesions and in cultured smooth muscle cells (4). Therefore, three MHC isoforms expressed in human vascular smooth muscle should provide important molecular tools to investigate smooth muscle phenotypes during vascular development as well as the progression of atherosclerosis.
Human vascular smooth muscle MHC isoforms are also differentially expressed depending on the developmental stage. Using isolated cDNA clones, we designed specific cRNA probes for RNase protection assay to detect three types of MHC mRNA in human aortas (11) (Fig. 3) . In the medial wall of the aorta, SM1 mRNA exists in large amount from the early development.
However, SM2 mRNA level was relatively low in the fetal aorta and significantly increased after birth. A difference between human and rabbit vascular MHC was seen in the expression of SMemb. In rabbits, SMemb quickly disappeared at 4 months after birth (4). SMemb mRNA in human aortas was decreased but did not disappeared after birth. Neither SM1-or SM2-mRNA was expressed in cultured A B In order to raise isoform-specific antibodies, three short peptides specifying the carboxyl terminal ends of SM1, SM2 and SMemb were synthesized and used for immunization (11). Using these antibodies, immunohistological studies were performed at various ages of human arteries. On immunohistochemistry, medial smooth muscle exhibited a developmental transition in MHC expression in human aortas and coronary arteries. Figure 4 shows that SM2 was not detectable in fetal coronary arteries (11). Both SM1 and SMemb were positive in the coronary artery through all ages, although the reactivities with antiSMemb antibody seemed to be decreased with aging.
The continued expression of SMemb in human aortas and coronary arteries makes a difference from rabbit in which SMemb was negative in adults. However, it is noteworthy that SMemb expression depends on the size of arteries because it was negative in such small-sized arteries as vasa vasorum or intramyocardial coronary arterioles in all cases studied (11). The physiological significance of continued expression of SMemb in large arteries is not known at the moment. We suggest it is important to clarify whether vascular smooth muscle expressing SMemb differ from those without SMemb in ultrastructures, contractile properties and the ability of proliferation. 
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Phenotypic modulation of intimal smooth muscle occurs prior to development of atherosclerotic changes
Human coronary arteries develop the intimal layer from the early adolescence, reaching several times thicker than the medial layer in the aged. Our immunohistological analyses indicated that the coronary intimal cells were for the most part smooth muscle cells because they reacted with both anti-SM1 (Fig. 4) (11) and anti-a-actin antibodies.
Intimal thickening with smooth muscle accumulation may be considered to be physiological in nature, but our recent study has demonstrated that smooth muscle in the thickened but non-atheromatous intima modulate their phenotype in light of the expression of MHC isoforms (11).
In a case of 18-year-old male of Fig. 4 , both medial and intimal smooth muscles of the left anterior descending coronary artery reacted equally with all three anti-MHC antibodies.
Smooth muscle in the moderately thickened coronary intima of a 33-year-old case showed reduced expression of SM2, which is a marker for well-differentiated smooth muscle, although smooth muscle in the thin (Fig. 6B) (11) . With more advanced atherosclerotic changes, a-actin expression besides all MHC isoforms was reduced (Fig. 7) . Thus , we suggest that immunohistochemistry for MHC isoforms is useful in determining transitional changes in smooth muscle phenotypes during progression of atherosclerosis. We also suggest that phenotypic modulation of smooth muscle cells even in non-atherosclerotic intima can be involved in the pathogenesis of coronary atherosclerosis.
Microvascular formation in deeper portion of human coronary intima
We have also demonstrated the presence of tiny vessels in the deeper layer of human coronary atherosclerotic plaques ( Fig. 8) 
